Related Experiment Video
Updated: Jan 28, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Culprit-Only or Complete Revascularization for ST-Elevation Myocardial Infarction in Patients with and Without Shock
Mark K Tuttle1, Duane S Pinto1
1Beth Israel Deaconess Medical Center, Harvard Medical School, 185 Pilgrim Road, West Campus, Baker 4, Boston, MA 02215, USA.
Insights
The optimal treatment for ST-elevation myocardial infarction (STEMI) with multivessel disease depends on patient factors. For STEMI patients in shock, mechanical support may be more beneficial than primary multivessel percutaneous coronary interventions (PCIs).
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- ST-elevation myocardial infarction (STEMI) with multivessel disease is common.
- Optimal management of non-culprit lesions in STEMI patients without shock is debated.
- STEMI patients experiencing cardiogenic shock may not benefit from immediate multivessel PCI.
Purpose of the Study:
- To review the current evidence and clinical considerations for managing multivessel disease in STEMI patients.
- To highlight the individualized treatment approach required for STEMI management.
- To discuss alternative therapies for STEMI patients with cardiogenic shock.
Main Methods:
- Review of existing clinical studies and guidelines.
- Analysis of patient data considering clinical, hemodynamic, and angiographic parameters.
- Discussion of percutaneous coronary interventions (PCI) versus other treatment strategies.
Main Results:
- Multivessel PCI in STEMI patients without shock requires careful consideration of non-culprit lesions.
- Primary multivessel PCI in STEMI patients with shock shows limited benefit.
- An individualized approach is crucial for optimizing STEMI treatment outcomes.
Conclusions:
- Treatment strategies for STEMI with multivessel disease should be tailored to individual patient profiles.
- Mechanical cardiovascular support may be a preferred option for STEMI patients with cardiogenic shock.
- Further research is needed to refine optimal treatment pathways for complex STEMI cases.
Abstract:
ST-elevation myocardial infarction (STEMI) patients with multivessel disease and without shock are a common clinical entity, but the best approach to nonculprit vessel lesions remains controversial. In contrast, STEMI patients with shock do not appear to benefit from primary multivessel percutaneous coronary interventions (PCIs) during the index procedure. The optimal treatment strategy in a given STEMI patient involves an individualized approach, incorporating clinical, hemodynamic, and angiographic/imaging parameters. Patients with STEMI and cardiogenic shock may benefit from therapies other than PCI, such as mechanical cardiovascular support.
Related Concept Videos
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Shock Waves
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
Elevation of Intermediate Points on Vertical Curves
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Patient-centered Care

